XHXiaohan Hu

Xiaohan Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaohan Hu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • HuiWen Wu

    Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing 210029, People’s Republic of China

    1 shared publication
  • Jiali Xu

    Laboratory Center for Basic Medical Sciences, Nanjing medical university Nanjing, 210029, PR China

    1 shared publication
  • Jin Zhou

    Department of General Surgery, The Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing 210006, PR China

    1 shared publication
  • Jun Guo

    Nanjing Medical University

    1 shared publication
  • Xiao Han

    Jiangsu Provincial Key Laboratory of Molecular Targets and Interventions for Metabolic Diseases, Department of Biochemistry and Molecular Biology, Nanjing Medical University 1 , Nanjing, China

    1 shared publication

Latest Publications

  • Open Access

    Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia

    by Xiaohan Hu, Xiangyang Wu, Jiali Xu, Jin Zhou, Xiao Han, Jun Guo

    Background: The regulation of protein phosphorylation requires a balance in the activity of protein kinases and protein phosphatases. Our previous data indicates that Src can increase ERK activity through Raf kinase in response to ischemic stimuli. This study examined the molecular mechanisms by which Src activates ERK cascade through protein phosphatases following cerebral ischemia. Results: Ischemia-induced Src activation is followed by phosphorylation of PP2A at Tyr307 leading to its inhibition in the rat hippocampus. SU6656, a Src inhibitor, up-regulates PP2A activity, resulting in a significant decreased activity in ERK and its targets, CREB and ERα. In addition, the PP2A inhibitor, cantharidin, led to an up-regulation of ERK activity and was able to counteract Src inhibition during ischemia. Conclusion: Src induces up-regulation of ERK activity and its target transcription factors, CREB and ERα, through attenuation of PP2A activity. Therefore, activation of ERK is the result of a crosstalk between two pathways, Raf-dependent positive regulators and PP2A-dependent negative regulators.